Literature DB >> 22004770

Different methods for ethical analysis in health technology assessment: an empirical study.

Samuli I Saarni1, Annette Braunack-Mayer, Bjørn Hofmann, Gert Jan van der Wilt.   

Abstract

OBJECTIVES: Ethical analysis can highlight important ethical issues related to implementing a technology, values inherent in the technology itself, and value-decisions underlying the health technology assessment (HTA) process. Ethical analysis is a well-acknowledged part of HTA, yet seldom included in practice. One reason for this is lack of knowledge about the properties and differences between the methods available. This study compares different methods for ethical analysis within HTA.
METHODS: Ethical issues related to bariatric (obesity) surgery were independently evaluated using axiological, casuist, principlist, and EUnetHTA models for ethical analysis within HTA. The methods and results are presented and compared.
RESULTS: Despite varying theoretical underpinnings and practical approaches, the four methods identified similar themes: personal responsibility, self-infliction, discrimination, justice, public funding, and stakeholder involvement. The axiological and EUnetHTA models identified a wider range of arguments, whereas casuistry and principlism concentrated more on analyzing a narrower set of arguments deemed more important.
CONCLUSIONS: Different methods can be successfully used for conducting ethical analysis within HTA. Although our study does not show that different methods in ethics always produce similar results, it supports the view that different methods of ethics can yield relevantly similar results. This suggests that the key conclusions of ethical analyses within HTA can be transferable between methods and countries. The systematic and transparent use of some method of ethics appears more important than the choice of the exact method.

Entities:  

Mesh:

Year:  2011        PMID: 22004770     DOI: 10.1017/S0266462311000444

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Methods for Practising Ethics in Research and Innovation: A Literature Review, Critical Analysis and Recommendations.

Authors:  Wessel Reijers; David Wright; Philip Brey; Karsten Weber; Rowena Rodrigues; Declan O'Sullivan; Bert Gordijn
Journal:  Sci Eng Ethics       Date:  2017-09-12       Impact factor: 3.525

2.  The Ethics of Precision Rationing: Human Genetics and the Need for Debate on Stratifying Access to Medication.

Authors:  Alexis Walker; Angie Boyce; Priya Duggal; Chloe L Thio; Gail Geller
Journal:  Public Health Genomics       Date:  2020-06-09       Impact factor: 2.000

3.  Beyond the Black Box Approach to Ethics! Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Lars Sandman; Erik Gustavsson
Journal:  Int J Health Policy Manag       Date:  2016-04-20

4.  Framework for systematic identification of ethical aspects of healthcare technologies: the SBU approach.

Authors:  Emelie Heintz; Laura Lintamo; Monica Hultcrantz; Stella Jacobson; Ragnar Levi; Christian Munthe; Sofia Tranæus; Pernilla Östlund; Lars Sandman
Journal:  Int J Technol Assess Health Care       Date:  2015-01       Impact factor: 2.188

5.  Do ethical considerations influence any in HTA reports? A review of reports.

Authors:  Alireza Shams Moattar; Fariba Asghari; Reza Majdzadeh
Journal:  Med J Islam Repub Iran       Date:  2016-05-03

6.  Why not integrate ethics in HTA: identification and assessment of the reasons.

Authors:  Bjørn Hofmann
Journal:  GMS Health Technol Assess       Date:  2014-11-26

7.  Ethical analysis in HTA of complex health interventions.

Authors:  Kristin Bakke Lysdahl; Wija Oortwijn; Gert Jan van der Wilt; Pietro Refolo; Dario Sacchini; Kati Mozygemba; Ansgar Gerhardus; Louise Brereton; Bjørn Hofmann
Journal:  BMC Med Ethics       Date:  2016-03-22       Impact factor: 2.652

8.  A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies.

Authors:  Ilda Hoxhaj; Laurenz Govaerts; Steven Simoens; Walter Van Dyck; Isabelle Huys; Iñaki Gutiérrez-Ibarluzea; Stefania Boccia
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.